Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy

Nagel, R., Cuttell, L., Stensvold, C. R., Mills, P. C., Bielefeldt-Ohmann, H. and Traub, R. J. (2012) Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy. Internal Medicine Journal, 42 11: 1187-1195. doi:10.1111/j.1445-5994.2011.02626.x

Author Nagel, R.
Cuttell, L.
Stensvold, C. R.
Mills, P. C.
Bielefeldt-Ohmann, H.
Traub, R. J.
Title Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy
Journal name Internal Medicine Journal   Check publisher's open access policy
ISSN 1444-0903
Publication date 2012-11-01
Sub-type Article (original research)
DOI 10.1111/j.1445-5994.2011.02626.x
Open Access Status Not Open Access
Volume 42
Issue 11
Start page 1187
End page 1195
Total pages 9
Place of publication Richmond, VIC Australia
Publisher Wiley-Blackwell Publishing Asia
Language eng
Formatted abstract
Background: Blastocystis is a common, enteric parasite. The pathogenicity of the organism is uncertain, but subtypes (ST) 1 and 3 have been reported more likely to cause irritable bowel-like symptoms.
Aims: We treated symptomatic patients positive for Blastocystis with conventional therapy and analysed 16 small-subunit (SSU) rDNA to assess clearance and carriage rates and ST prevalence of the parasite in the asymptomatic household members.
Methods: In a longitudinal, prospective case study, 11 symptomatic patients positive for Blastocystis underwent outpatient clinical assessment to exclude other diagnoses before 14 days of either metronidazole 400mg three times daily or trimethoprim/sulfamethoxazole 160/800mg twice-daily therapy. Faecal specimens were collected from patients at baseline, day 15, 28 and 56 after therapy and from 17 family members and eight pets at day 15. Specimens were analysed using faecal smear, culture and polymerase chain reaction analysis of 16SSU rDNA.
: No patient cleared the organism following therapy. ST 1 (45%), 3 (36%), 4 (36%) and 6 (9%) were found in the symptomatic Blastocystis patients, and ST identified before and after therapy were identical in each individual. All household contacts were positive for Blastocystis and 16/17 (94%) contacts showed identical Blastocystis ST to the symptomatic family member. All pets were positive for Blastocystis with polymerase chain reaction testing, 7/8 (88%) demonstrating ST concordance with the symptomatic Blastocystis patients.
Conclusions: Conventional therapy is ineffective for symptomatic Blastocystis infection. The high prevalence of Blastocystis infection within households suggested transmission between humans and their pets. Subtyping analysis of SSU rDNA alone in Blastocystis does not appear to predict pathogenicity.
Keyword Blastocystis
Irritable Bowel Syndrome
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2013 Collection
School of Medicine Publications
School of Veterinary Science Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 28 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 30 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 23 Dec 2012, 11:02:32 EST by System User on behalf of School of Veterinary Science